From ASX announcement on 5/9/17.
'"Consideration payable by PSY for the acquisition will be a combination of up to $2 million cash and the issue of 50 million new PSY shares"
"The total maximum cash consideration payable by PSY for the acquisition is $2 million, which comprises an upfront cash consideration component and a deferred earn-out cash consideration component, which will be payable progressively upon achievement of prescribed performance targets"
HYD Price at posting:
2.5¢ Sentiment: None Disclosure: Held
